INVO Bioscience
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of INVO Bioscience generated cash of -$4,755,054, which is more than the previous year. Cash used in financing activities reached the amount of $7,392,222 last year. Net change in cash is therefore $142,289.
Cash Flow
| 2014 | -19.40K | 0 | 20K |
|---|---|---|---|
| 2015 | -151.62K | 0 | 625K |
| 2016 | -323.9K | -15.7K | 1.26M |
| 2017 | -181.27K | 0 | 54.62K |
| 2018 | -652.97K | -19.4K | 858.85K |
| 2019 | 1.37M | -114.70K | -229.46K |
| 2020 | -4.77M | -187.25K | 13.82M |
| 2021 | -6.02M | -2.15M | 3.77M |
| 2022 | -6.60M | -81.21K | 1.08M |
| 2023 | -4.75M | -2.49M | 7.39M |
INVO Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 90.13K | 5.68M | 10.09M | 1.23M | 212.24K | 25.75K | 152.40K | 492.00K | 18.62K | 18.02K |
Operating activities | ||||||||||
Net income | -8.03M | -10.89M | -6.65M | -8.34M | -2.16M | -3.07M | -702.16K | -2.12M | -4.95M | -1.73M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 200.89K | 306.31K | 166.08K | 34.48K | 25.34K | 5.19K | 2.81K | 1.87K | 5.63K | 10.53K |
Stock-based compensation expense | 1.39M | 2.22M | 2.70M | 1.75M | 133.53K | 0 | 215.13K | 1.26M | 91.31K | 1.16M |
| Deferred income tax benefit | 1.39M | 2.22M | 2.70M | 1.75M | 133.53K | 0 | 215.13K | 1.26M | 91.31K | 1.16M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -63.40K | -26.67K | -28.77K | -14.14K | 218.34K | -139.20K | -83.90K | -1.44K | -1.02K | 1.44K |
Inventories | -905 | 24.17K | -22.40K | -163.98K | -57.87K | 15.36K | 26.33K | -19.79K | -2.96K | 3.11K |
Accounts payable | 924.67K | 904.06K | 114.49K | -42.60K | -200.29K | -377.81K | -5.34K | 82.81K | -6.29K | 0 |
Cash generated by operating activities | -4.75M | -6.60M | -6.02M | -4.77M | 1.37M | -652.97K | -181.27K | -323.9K | -151.62K | -19.40K |
Investing activities | ||||||||||
Purchases Of Investments | -8.44K | -68.48K | -1.69M | -98.08K | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -444.72K | -12.72K | -454.64K | -88.93K | -114.70K | -19.4K | 0 | -15.7K | 0 | 0 |
Acquisitions Net | -2.05M | -68.48K | -1.69M | -98.08K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -2.49M | -81.21K | -2.15M | -187.25K | -114.70K | -19.4K | 0 | -15.7K | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 5.70M | 289.8K | 3.65M | 11.47M | 0 | 77K | 54.62K | 1.26M | 645K | 20K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 1.66M | 0 | -250K | -810K | -97.74K | -113.14K | 0 | 0 | 0 | 0 |
Cash used in financing activities | 7.39M | 1.08M | 3.77M | 13.82M | -229.46K | 858.85K | 54.62K | 1.26M | 625K | 20K |
Net Change In Cash | 142.28K | -5.59M | -4.41M | 8.85M | 1.02M | 186.48K | -126.64K | -339.6K | 473.37K | 599 |
Cash at end of period | 232.42K | 90.13K | 5.68M | 10.09M | 1.23M | 212.24K | 25.75K | 152.40K | 492.00K | 18.62K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |